HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A A Ansari Selected Research

2-octynoic acid

8/2014Innate immunity drives xenobiotic-induced murine autoimmune cholangitis.
6/2012The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.
10/2011The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A A Ansari Research Topics

Disease

13Infections
01/2016 - 04/2000
11Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
06/2015 - 01/2000
8Cholangitis
01/2016 - 03/2009
3Inflammation (Inflammations)
01/2016 - 06/2012
3Autoimmune Diseases (Autoimmune Disease)
01/2016 - 07/2001
2Necrosis
06/2012 - 08/2007
2Hypersensitivity (Allergy)
12/2007 - 08/2007
2Human Influenza (Influenza)
09/2004 - 06/2001
2Acquired Immunodeficiency Syndrome (AIDS)
11/2001 - 05/2000
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2016
1Colitis
01/2016
1Fibrosis (Cirrhosis)
08/2014
1Hyperthermia
01/2014
1Blister (Bulla)
04/2013
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2011
1Thrombocytopenia (Thrombopenia)
08/2011
1Granuloma
03/2009
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
06/2003
1Gastroenteritis
03/2002
1HIV Infections (HIV Infection)
11/2001
1Cocaine-Related Disorders (Cocaine Addiction)
11/2001
1Cardiomyopathies (Cardiomyopathy)
11/2001
1Liver Diseases (Liver Disease)
07/2001
1Hantavirus Infections
07/2001
1Persistent Infection
06/2001
1Virus Diseases (Viral Diseases)
06/2001
1Viremia
07/2000

Drug/Important Bio-Agent (IBA)

8CytokinesIBA
01/2016 - 04/2000
6AntibodiesIBA
08/2014 - 01/2000
4InterleukinsIBA
01/2016 - 08/2007
4XenobioticsIBA
08/2014 - 07/2001
4AutoantibodiesIBA
06/2012 - 04/2001
4AntigensIBA
10/2011 - 01/2000
32-octynoic acidIBA
08/2014 - 10/2011
3AutoantigensIBA
12/2013 - 10/2001
3Interleukin-12 (IL 12)IBA
08/2007 - 05/2000
3Antiviral Agents (Antivirals)IBA
02/2002 - 05/2000
2Biological ProductsIBA
01/2016 - 01/2014
2Interleukin-12 Subunit p40IBA
01/2016 - 06/2012
2Interleukin-23 Subunit p19IBA
01/2016 - 06/2012
2Interleukin-17 (Interleukin 17)IBA
01/2016 - 06/2012
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2016 - 11/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
06/2015 - 12/2013
2Bovine Serum AlbuminIBA
08/2014 - 06/2012
2Monoclonal AntibodiesIBA
12/2013 - 10/2001
2LigandsIBA
12/2013 - 08/2007
2Toll-Like Receptors (Toll-Like Receptor)IBA
04/2013 - 08/2007
2InterferonsIBA
06/2012 - 07/2001
2Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
06/2012 - 10/2011
2Thioctic Acid (Lipoic Acid)IBA
06/2012 - 04/2001
2Pyruvic Acid (Pyruvate)IBA
03/2009 - 10/2001
2Oxidoreductases (Dehydrogenase)IBA
03/2009 - 10/2001
2AminesIBA
12/2007 - 08/2007
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2007 - 12/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 05/2000
2Proteins (Proteins, Gene)FDA Link
09/2004 - 07/2001
2Tetanus Toxoid (Vaccine, Tetanus)FDA Link
09/2004 - 06/2001
2Matrix Metalloproteinases (MMPs)IBA
06/2003 - 11/2001
2Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2003 - 11/2001
1Interleukin-22 (IL-22)IBA
01/2016
1CTLA-4 AntigenIBA
06/2015
1Immunoglobulins (Immunoglobulin)IBA
06/2015
1RezafunginIBA
11/2014
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
11/2014
1Glycoproteins (Glycoprotein)IBA
11/2014
1CosmeticsIBA
08/2014
1Galactosylceramides (Galactocerebrosides)IBA
08/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
08/2014
1CD40 Ligand (CD40L)IBA
12/2013
1Nuclear Proteins (Protein, Nuclear)IBA
06/2012
1Lysine (L-Lysine)FDA Link
06/2012
1Interleukin-6 (Interleukin 6)IBA
06/2012
1EpitopesIBA
06/2012
1Poly I-CIBA
10/2011
1Dextrans (Dextran)FDA Link
08/2007
1Interleukin-2 (IL2)IBA
09/2004
1Interleukin-15 (Interleukin 15)IBA
09/2004
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2003
1E-SelectinIBA
06/2003
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2003
1VaccinesIBA
03/2002
1Viral RNAIBA
03/2002
1Oligonucleotide ProbesIBA
03/2002
1RNA (Ribonucleic Acid)IBA
03/2002
1DNA (Deoxyribonucleic Acid)IBA
02/2002
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2001
1Protein Kinases (Protein Kinase)IBA
12/2001
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
07/2001
1ChemokinesIBA
07/2001
1Chemokine CCL5IBA
07/2001
1Tumor Viral Antigens (Large T Antigen)IBA
06/2001
1Terminator Codon (Termination Codon)IBA
12/2000
1Pharmaceutical PreparationsIBA
07/2000
1Reverse Transcriptase InhibitorsIBA
07/2000
1GW420867IBA
07/2000
1Telomerase (Telomerase Reverse Transcriptase)IBA
06/2000

Therapy/Procedure

4Therapeutics
01/2016 - 07/2000
1Duration of Therapy
06/2015
1Immunotherapy
11/2014
1Splenectomy
08/2011